Literature DB >> 9931344

A Pro51Ser mutation in the COCH gene is associated with late onset autosomal dominant progressive sensorineural hearing loss with vestibular defects.

Y J de Kok1, S J Bom, T M Brunt, M H Kemperman, E van Beusekom, S D van der Velde-Visser, N G Robertson, C C Morton, P L Huygen, W I Verhagen, H G Brunner, C W Cremers, F P Cremers.   

Abstract

We analysed a Dutch family with autosomal dominant non-syndromic progressive sensorineural hearing loss and mapped the underlying gene defect by genetic linkage analysis to a 11.0 cM region overlapping the DFNA9 interval on chromosome 14q12-q13. Clinically, the Dutch family differs from the original DFNA9 family by a later age at onset and a more clearly established vestibular impairment. A gene that is highly and specifically expressed in the human fetal cochlea and vestibule, COCH (previously described as Coch5B2 ), was mapped to the DFNA9 critical region. Sequence analysis revealed a 208C-->T mutation in the COCH gene, resulting in a Pro51Ser substitution in the predicted protein in all affected individuals of the family but not in unaffected family members and 200 control individuals. The same mutation was also identified in three apparently unrelated families with a similar phenotype, suggesting the presence of a Dutch founder mutation. The function of COCH is unknown but several characteristics of the protein point to a structural role in the extracellular matrix. The mutant serine at position 51 is situated between cysteines and possibly interferes with proper COCH protein folding or its interaction with extracellular matrix proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931344     DOI: 10.1093/hmg/8.2.361

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  31 in total

1.  Hearing and vestibular deficits in the Coch(-/-) null mouse model: comparison to the Coch(G88E/G88E) mouse and to DFNA9 hearing and balance disorder.

Authors:  Sherri M Jones; Nahid G Robertson; Shelly Given; Anne B S Giersch; M Charles Liberman; Cynthia C Morton
Journal:  Hear Res       Date:  2010-11-10       Impact factor: 3.208

2.  Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study.

Authors:  Georgios K Tsirves; Paraskevi V Voulgari; Eleftherios Pelechas; Asimakis D Asimakopoulos; Alexandros A Drosos
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-30       Impact factor: 2.503

Review 3.  Genes important for otoneurological diagnostic purposes - current status and future prospects.

Authors:  K Pawlak-Osiñska; K Linkowska; T Grzybowski
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-06       Impact factor: 2.124

4.  Distinct vestibular phenotypes in DFNA9 families with COCH variants.

Authors:  Bong Jik Kim; Ah Reum Kim; Kyu-Hee Han; Yoon Chan Rah; Jaihwan Hyun; Brandon S Ra; Ja-Won Koo; Byung Yoon Choi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-13       Impact factor: 2.503

5.  Identification of pathogenic mechanisms of COCH mutations, abolished cochlin secretion, and intracellular aggregate formation: genotype-phenotype correlations in DFNA9 deafness and vestibular disorder.

Authors:  Seung-Hyun Bae; Nahid G Robertson; Hyun-Ju Cho; Cynthia C Morton; Da Jung Jung; Jeong-In Baek; Soo-Young Choi; Jaetae Lee; Kyu-Yup Lee; Un-Kyung Kim
Journal:  Hum Mutat       Date:  2014-12       Impact factor: 4.878

Review 6.  Inheritance patterns of progressive hearing loss in laboratory strains of mice.

Authors:  Konrad Noben-Trauth; Kenneth R Johnson
Journal:  Brain Res       Date:  2009-02-21       Impact factor: 3.252

7.  Proteomics reveal Cochlin deposits associated with glaucomatous trabecular meshwork.

Authors:  Sanjoy K Bhattacharya; Edward J Rockwood; Scott D Smith; Vera L Bonilha; John S Crabb; Rachel W Kuchtey; Nahid G Robertson; Neal S Peachey; Cynthia C Morton; John W Crabb
Journal:  J Biol Chem       Date:  2004-12-03       Impact factor: 5.157

8.  Targeted disruption of mouse Coch provides functional evidence that DFNA9 hearing loss is not a COCH haploinsufficiency disorder.

Authors:  Tomoko Makishima; Clara I Rodriguez; Nahid G Robertson; Cynthia C Morton; Colin L Stewart; Andrew J Griffith
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

9.  Subcellular localisation, secretion, and post-translational processing of normal cochlin, and of mutants causing the sensorineural deafness and vestibular disorder, DFNA9.

Authors:  N G Robertson; S A Hamaker; V Patriub; J C Aster; C C Morton
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

10.  A targeted Coch missense mutation: a knock-in mouse model for DFNA9 late-onset hearing loss and vestibular dysfunction.

Authors:  Nahid G Robertson; Sherri M Jones; Theru A Sivakumaran; Anne B S Giersch; Sara A Jurado; Linda M Call; Constance E Miller; Stéphane F Maison; M Charles Liberman; Cynthia C Morton
Journal:  Hum Mol Genet       Date:  2008-08-12       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.